Deals
First Crypto and Cannabis. Now Psychedelics
- Clarify Pharma raised $2.3 million on the Aquis Stock Exchange
- IPO is fourth for Jonathan Bixby, Mike Edwards in eight months
Psilocybin mushrooms.
Photographer: Jahi Chikwendiu/The Washington Post/Getty Images
This article is for subscribers only.
Jonathan Bixby and Mike Edwards, the duo that’s taken public companies involved in cryptocurrencies, e-sports and cannabis, are back with a fourth London listing in eight months. This time, it’s psychedelics.
Clarify Pharma invests in biotech and life-sciences companies seeking to prove the safety and efficacy of psychedelic-based substances. It raised 1.96 million pounds ($2.3 million) on the Aquis Stock Exchange, a small U.K. bourse. The stock opened at 2.77 pence, up 11% from the 2.50 pence listing price.